Literature DB >> 30051367

Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial.

Hyung Soon Park1,2, Hyo Song Kim1, Seung Hoon Beom1, Sun Young Rha1, Hyun Cheol Chung1, Jee Hung Kim1, You Jin Chun1, Si Won Lee1, Eun-Ah Choe1, Su Jin Heo1, Sung Hoon Noh3, Woo Jin Hyung3, Jae-Ho Cheong3, Hyoung-Il Kim3, Taeil Son3, Joon Seok Lim4, Song-Ee Baek5, Minkyu Jung6.   

Abstract

BACKGROUND: There is increasing interest in the influence of body composition on oncological outcomes. We evaluated the role of skeletal muscle and fat among patients with gastric cancer (GC) who underwent gastrectomy with or without adjuvant chemotherapy, as well as those changes' associations with survival outcomes.
METHODS: The present study evaluated 136 patients with GC who were enrolled in the CLASSIC Trial at Yonsei Cancer Center. Baseline body compositions including skeletal muscle area, Hounsfield units (HU), visceral fat area, and subcutaneous fat area were measured by preoperative computed tomography (CT). CT before and after the gastrectomy were used to determine the 6-month relative changes in body composition parameters. Continuous variables were dichotomized according to the best cutoff values by Contal and O'Quigley method.
RESULTS: Seventy-three patients (53.7%) underwent surgery alone, and 63 patients (46.3%) underwent surgery followed by adjuvant chemotherapy. The baseline body composition parameters were not associated with disease-free survival (DFS) or overall survival (OS). Except for the HU, the marked loss of muscle, visceral fat, or subcutaneous fat significantly predicted shorter DFS and OS. Patients with a marked loss in at least one significant body composition parameter had significantly shorter DFS (hazard ratio 2.9, 95% confidence interval 1.7-4.8, P < 0.001) and OS (hazard ratio 2.9, 95% confidence interval 1.7-5.0, P < 0.001).
CONCLUSIONS: Marked loss in body composition parameters significantly predicted shorter DFS and OS among patients with GC who underwent gastrectomy. Postoperative nutrition and active healthcare interventions could improve the prognosis of these GC patients.

Entities:  

Mesh:

Year:  2018        PMID: 30051367     DOI: 10.1245/s10434-018-6624-1

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  13 in total

1.  Preoperative Muscle-Adipose Index: A New Prognostic Factor for Gastric Cancer.

Authors:  Jun Lu; Zhen Xue; Jian-Gao Xie; Bin-Bin Xu; Hai-Bo Yang; Dong Wu; Hua-Long Zheng; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Qi-Yue Chen; Ping Li; Chang-Ming Huang; Chao-Hui Zheng
Journal:  Ann Surg Oncol       Date:  2022-03-16       Impact factor: 5.344

2.  Benefit of laparoscopic compared to standard open gastric cancer surgery for sarcopenic patients: a propensity score-matching analysis.

Authors:  Tsuneyuki Uchida; Ryuichi Sekine; Kenichi Matsuo; Gaku Kigawa; Takahiro Umemoto; Kuniya Tanaka
Journal:  Surg Endosc       Date:  2022-07-15       Impact factor: 3.453

Review 3.  Adiposity and cancer survival: a systematic review and meta-analysis.

Authors:  Elizabeth M Cespedes Feliciano; Bette J Caan; En Cheng; Jocelyn Kirley
Journal:  Cancer Causes Control       Date:  2022-08-15       Impact factor: 2.532

4.  Billroth II anastomosis maintains SMI and BMI better than Roux-en-Y anastomosis following totally laparoscopic distal gastrectomy: a propensity score-matched study.

Authors:  Linhua Jiang; Jiawen Zhang; Xinguo Zhu
Journal:  Langenbecks Arch Surg       Date:  2022-02-06       Impact factor: 2.895

5.  Feasibility of augmented rectangle technique in laparoscopic distal gastrectomy: comparison with hemi-double stapling technique in a single-center retrospective cohort study.

Authors:  Ryohei Nishiguchi; Takao Katsube; Takeshi Shimakawa; Shinichi Asaka; Miki Miyazawa; Kentaro Yamaguchi; Minoru Murayama; Takebumi Usui; Hajime Yokomizo; Seiji Ohigashi; Shunichi Shiozawa
Journal:  Langenbecks Arch Surg       Date:  2021-11-23       Impact factor: 2.895

6.  Larger Remaining Stomach Volume Is Associated With Better Nutrition and Muscle Preservation in Patients With Gastric Cancer Receiving Distal Gastrectomy With Gastroduodenostomy.

Authors:  Amy Kim; Jung-Bok Lee; Yousun Ko; Taeyong Park; Hyeonjong Jo; Jin Kyoo Jang; Kyoungsuk Lee; Kyung Won Kim; In-Seob Lee
Journal:  J Gastric Cancer       Date:  2022-04       Impact factor: 3.720

7.  Sarcopenia as a prognostic factor for survival in patients with locally advanced gastroesophageal adenocarcinoma.

Authors:  Christine Koch; Cornelius Reitz; Teresa Schreckenbach; Katrin Eichler; Natalie Filmann; Salah-Eddin Al-Batran; Thorsten Götze; Stefan Zeuzem; Wolf Otto Bechstein; Thomas Kraus; Jörg Bojunga; Markus Düx; Jörg Trojan; Irina Blumenstein
Journal:  PLoS One       Date:  2019-10-22       Impact factor: 3.240

8.  Prognostic Value of Pretreatment Overweight/Obesity and Adipose Tissue Distribution in Resectable Gastric Cancer: A Retrospective Cohort Study.

Authors:  Lihu Gu; Yangfan Zhang; Jiaze Hong; Binbin Xu; Liuqiong Yang; Kun Yan; Jingfeng Zhang; Ping Chen; Jianjun Zheng; Jie Lin
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244

9.  CT-assessed sarcopenia is a predictive factor for both long-term and short-term outcomes in gastrointestinal oncology patients: a systematic review and meta-analysis.

Authors:  Huaiying Su; Junxian Ruan; Tianfeng Chen; Enyi Lin; Lijing Shi
Journal:  Cancer Imaging       Date:  2019-12-03       Impact factor: 3.909

Review 10.  Multimodality Treatment in Metastatic Gastric Cancer: From Past to Next Future.

Authors:  Alessandro Parisi; Giampiero Porzio; Corrado Ficorella
Journal:  Cancers (Basel)       Date:  2020-09-11       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.